Apolipoprotein A1 and Transferrin as Biomarkers in Ovarian Cancer Diagnostics

Banks RE, Dunn MJ, Forbes MA, Stanley A, Pappin D, Naven T, Gough M, Harnden P, Selby PJ. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis-preliminary findings // Electrophoresis, 1999; 20:689-70010.1002/(SICI)1522-2683(19990101)20:4/5<689::AID-ELPS689>3.0.CO;2-JSearch in Google Scholar

Becker W, Rapp W, Schwick HG, Störiko KZ. Methods for the quantitative determination of plasma proteins by immunoprecipitation // Klin Chem Klin Biochem, 1968; 6:113-22Search in Google Scholar

Feng S, Lang J, Kumar A, Carey N, Hsieh B, Suchard MA., Reddy ST, Farias-Eisner R. Validation of Candidate Serum Ovarian Cancer Biomarkers for Early Detection // Biomarker Insights, 2007; 2:369-375Search in Google Scholar

Fung ET, Thulasiraman V, Weinberger SR, Dalmasso EA. Protein biochips for differential profiling // (a) Curr Opin Biotechnol, 2001;12:65-6910.1016/S0958-1669(00)00167-1Search in Google Scholar

Fung ET, Wright GL Jr, Dalmasso EA. Proteomic strategies for biomarker identification: progress and challenges // (b) Curr Opin Mol Ther, 2000; 2:643-650Search in Google Scholar

Goufman EI, Moshkovskii SA, Tikhonova OV, Lokhov PG, Zgoda VG, Serebryakova MV, Toropygin IY, Vlasova MA, Safarova MR, Makarov OV, Archakov AI. Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions // Biochemistry (Mosc), 2006; 71(4):354-6010.1134/S000629790604002XSearch in Google Scholar

Heidelberg M, Kendall FE // J Exp Med, 1935; 62:69710.1084/jem.62.5.697Search in Google Scholar

Hood BL, Malehorn DE, Conrads TP, Bigbee WL. Serum proteomics using mass spectrometry // Methods Mol Biol, 2009; 520:107-2810.1007/978-1-60327-811-9_8Search in Google Scholar

Jacobs I, Bast RC Jr. The CA 125 tumour-associated antigen: a review of the literature // Hum Reprod, 1989; 4:1-1210.1093/oxfordjournals.humrep.a136832Search in Google Scholar

Kozak KR, Su F, Whitelegge JP, Faull K, Reddy S, Farias-Eisner R. Characterization of serum biomarkers for detection of early stage ovarian cancer // Proteomics, 2005; 5(17):4589-9610.1002/pmic.200500093Search in Google Scholar

Lizana J, Hellsing K. Manual immunoephelometric assay of proteins, with use of polymer enhancement // Clin Chem, 1974; 20:1181-610.1093/clinchem/20.9.1181Search in Google Scholar

MacDonald ND, Jacobs IJ. Is there a place for screening in ovarian cancer // Eur J Obstet Gynecol Reprod Biol, 1999; 82:155-15710.1016/S0301-2115(98)00219-XSearch in Google Scholar

Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization time-of-flight mass spectrometry // Electrophoresis, 2000; 21:1164-117710.1002/(SICI)1522-2683(20000401)21:6<1164::AID-ELPS1164>3.0.CO;2-0Search in Google Scholar

Moore LE, Fung ET, McGuire M, Rabkin CC, Molinaro A, Wang Z, Zhang F, Wang J, Yip C, Meng XY, Pfeiffer RM. Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population // Cancer Epidemiol Biomarkers Prev, 2006; 15(9):1641-610.1158/1055-9965.EPI-05-0980Search in Google Scholar

Naito HK. Reliability of lipid, lipoprotein, and apolipoprotein measurements // Clin Chem, 1988; 34:84-9410.1093/clinchem/34.11.2224Search in Google Scholar

Nosov V, Su F, Amneus M, Birrer M, Robins T, Kotlerman J, Reddy S, Farias-Eisner R. Validation of serum biomarkers for detection of early-stage ovarian cancer // Am J Obstet Gynecol, 2009; 200:63910.1016/j.ajog.2008.12.042Search in Google Scholar

Palmer-Toy D, Kuzdzal S, Chan, DW. Proteomic approaches to tumor marker discovery // In: Diamandis EP, Fritsche H, Lilja H, Chan DW, Schwartz M, eds. Tumor Markers Physiology, Pathobiology, Technology and Clinical Applications. Philadelphia: AACC Press; 2002; 391-400Search in Google Scholar

Paweletz CP, Gillespie JW, Ornstein DK, Simone NL, Brown MR, Cole KA, Wang QH, Huang J, Hu N, Yip TT, Rich WE, Kohn EC, Linehan WM, Weber T, Taylor P, Emmert-Buck MR, Liotta LA, Petricoin EF. Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip // Drug Dev Res, 2000; 49:34-4210.1002/(SICI)1098-2299(200001)49:1<34::AID-DDR6>3.0.CO;2-WSearch in Google Scholar

Rai AJ, Zhang Z, Rosenzweig J, Shih I, Pham T, Fung ET, Sokoll LJ, Chan DW. Proteomic Approaches to Tumor Marker Discovery Identification of Biomarkers for Ovarian Cancer // Arch Pathol Lab Med, 2002; 126(12):1518-152610.5858/2002-126-1518-PATTMDSearch in Google Scholar

Rifai N, King ME. Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum // Clin Chem, 1986; 32:957-6110.1093/clinchem/32.6.957Search in Google Scholar

Shih IM, Sokoll LJ, Chan DW, Tumor markers in ovarian cancer // In: Diamandis EP, Fritsche H, Lilja H, Chan DW, Schwartz M. Tumor Markers Physiology, Pathobiology, Technology and Clinical Applications. Philadelphia: AACC Press; 2002; 239-252 Siedel, J., Schiefer, S., Rosseneu, M., Bergeaud, R., De Keersgieter, W., Pautz, B., Vinaimont, N., Ziegenhorn, J. Immunoturbidimetric method for routine determinations of apolipoproteins A-I, A-I. I., and B in normo- and hyperlipemic sera compared with immunonephelometry // Clin Chem, 1988; 34:1821-5Search in Google Scholar

Tietz NW. Transferrin // In: Tietz NW. Fundamentals of clinical Chemistry. 2nd ed. Philadelphia: WB Saunders; 1976; 278-280Search in Google Scholar

Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, Nasim S, Wright Jr. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine // Am J Pathol, 2001; 158:1491-150210.1016/S0002-9440(10)64100-4Search in Google Scholar

Von Eggeling F, Junker K, Fiedler W, Wollscheid V, Dürst M, Claussen U, Ernst G. Mass spectrometry meets chip technology: a new proteomic tool in cancer research // Electrophoresis, 2001; 22: 2898-290210.1002/1522-2683(200108)22:14<2898::AID-ELPS2898>3.0.CO;2-ASearch in Google Scholar

Weinberger SR, Morris TS, Pawlak M. Recent trends in protein biochip technology // Pharmacogenomics, 2000; 1:395-41610.1517/14622416.1.4.395Search in Google Scholar

Zhang Z, Bast RC, Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng XY, Berchuck A, Van Haaften-Day C, Hacker NF, de Bruijn HWA, Van der Zee AGJ, Jacobs IJ, Fung ET, Chan DW. Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer // Cancer Research, 2004; 64:5882-589010.1158/0008-5472.CAN-04-0746Search in Google Scholar

Zhao Q, Duan W, Wu YM, Qian XH, Deng XH. Analysis of serum biomarkers of ovarian epithelial cancers based on 2-DE DIGE and MALDI TOF/TOF // Zhonghua Zhong Liu Za Zhi, 2008; 30(10):754-8Search in Google Scholar